TG Therapeutics | TGTX - Fremdkapital





Fremdkapital Veränderung Datum
AbbVie USD 64.53B 5.59B 2026-03
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Amgen USD 51.86B 27M 2026-06
Ardelyx USD 203.52M 683K 2026-03
Arrowhead Research USD 824.07M 401.34M 2026-06
Bayer EUR 31.16B 480M 2026-06
Biogen USD 7.29B 1B 2026-06
Curis USD 29.43M 10.69M 2024-06
Gilead Sciences USD 20.86B 1.27B 2026-03
J&J USD 37.34B 183M 2026-06
Karyopharm Therapeutics USD 264.49M 13.73M 2026-03
Novartis USD 37.49B 42M 2026-06
Novavax USD 246.3M 200K 2025-12
PTC Therapeutics USD 535.52M 248.58M 2026-06
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
TG Therapeutics USD 745.39M 247K 2026-06
Verastem USD 76.87M 4.46M 2026-03
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12